ADMA Biologics, Inc.ADMANASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank86
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Percentile
P86
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
202521.93-18.6%
202426.92-87.5%
2023215.32+1118.1%
2022-21.15-351.6%
2021-4.68-33.6%
2020-3.51+54.1%
2019-7.64-235.2%
2018-2.28-22.2%
2017-1.87+56.8%
2016-4.32-